| Identification | Back Directory | [Name]
(3S,4S)-Tofacitinib | [CAS]
1092578-47-6 | [Synonyms]
15(3R4S,3S4R）
SS-tofacitinib
Tofacitinib-15
ent-Tofacitinib
Tofacitinib 3S,4S
(3S,4S)-Tofacitinib
Tofacitinib Impurity C
Tofacitinib IMpurity A
Tofacitinib Impurity C(3S,4S)
Tofacitinib Impurity Q Citrate
Tofacitinib IMpurity C Citrate
Tofacitinib Impurity 17 Monomer
3-((3S,4S)-4-methyl-3-(methyl(7Hpyrrolo[2,3-d]pyrimidin-4-yl)
(3S,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile
(3S,4S)-4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-beta-oxo-1-piperidinepropanenitrile
1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-, (3S,4S)-
2-isocyano-1-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethanone
3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
SIM2908 3-((3S,4S)-4-methyl-3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
Tofacitinib impurity 11/(3S,4S)-Tofacitinib/3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino) piperidin-1-yl)-3-oxopropanenitrile | [Molecular Formula]
C16H20N6O | [MDL Number]
MFCD11035920 | [MOL File]
1092578-47-6.mol | [Molecular Weight]
312.37 |
| Chemical Properties | Back Directory | [density ]
1.296 | [storage temp. ]
Store at -20°C | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Powder | [pka]
6.04±0.60(Predicted) | [color ]
Off-white to pink | [InChI]
InChI=1/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/s3 | [InChIKey]
UJLAWZDWDVHWOW-BCFRMRSDNA-N | [SMILES]
C(#N)CC(N1CC[C@H](C)[C@H](N(C)C2=NC=NC3NC=CC=32)C1)=O |&1:7,9,r| |
|
|